Literature DB >> 1964095

Efficient packaging of a specific VL30 retroelement by psi 2 cells which produce MoMLV recombinant retroviruses.

M Hatzoglou1, C P Hodgson, F Mularo, R W Hanson.   

Abstract

FTO-2B rat hepatoma cells acquired mouse VL30 retrotransposon(s) when infected with Moloney murine leukemia virus (MoMLV) recombinant retroviruses produced from psi 2 cells. The VL30 provirus was integrated into the rat genome, expressed at high levels, and its transcription induced 40-fold by dexamethasone, VL30 RNA was detected in hepatoma cells even without selection for the expression of the amino-3'-glycosyl phosphotransferase (neo) gene, which was co-transferred with a MoMLV retrovirus. However, the extent of transfer of the VL30 RNA was inversely related to the titer of the MoMLV recombinant retrovirus. The restriction map analysis of the transferred VL30 provirus was identical to the mouse VL30s of the NVL subfamily which is known to be a significant fraction of the transcriptionally active VL30 subset. Additionally, the regenerating liver from an adult rat, which was infected with a defective MoMLV-derived retrovirus, expressed VL30 RNA. These results indicate that great care should be given to the transfer of unwanted passengers, like VL30, present in retroviral packaging cell lines like the psi 2 cells, which are currently being used for gene therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964095     DOI: 10.1089/hum.1990.1.4-385

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  11 in total

1.  Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons.

Authors:  M Sena-Esteves; Y Saeki; S M Camp; E A Chiocca; X O Breakefield
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Retrovirus-like particles released from the human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences.

Authors:  W Seifarth; H Skladny; F Krieg-Schneider; A Reichert; R Hehlmann; C Leib-Mösch
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

3.  Extended minus-strand DNA as template for R-U5-mediated second-strand transfer in recombinational rescue of primer binding site-modified retroviral vectors.

Authors:  J G Mikkelsen; A H Lund; K Dybkaer; M Duch; F S Pedersen
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocalization of gp70 and target cells on fibronectin CH-296.

Authors:  E C MacNeill; H Hanenberg; K E Pollok; J C van der Loo; M F Bierhuizen; G Wagemaker; D A Williams
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Identification of an internal ribosome entry segment in the 5' region of the mouse VL30 retrotransposon and its use in the development of retroviral vectors.

Authors:  M López-Lastra; S Ulrici; C Gabus; J L Darlix
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Functional analysis of the murine sarcoma virus RNA packaging sequence.

Authors:  Elena Izmailova; Anna Aldovini
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.

Authors:  C Patience; Y Takeuchi; F L Cosset; R A Weiss
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 8.  Evolution and biological significance of human retroelements.

Authors:  C Leib-Mösch; W Seifarth
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

9.  Sequence analysis of Mus dunni endogenous virus reveals a hybrid VL30/gibbon ape leukemia virus-like structure and a distinct envelope.

Authors:  G Wolgamot; L Bonham; A D Miller
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  RNA sequences in the Moloney murine leukemia virus genome bound by the Gag precursor protein in the yeast three-hybrid system.

Authors:  Matthew J Evans; Eran Bacharach; Stephen P Goff
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.